Mayne Pharma drugs

6 results

  • fabior

    (tazarotene)
    Mayne Pharma
    FABIOR® (tazarotene) Foam, 0.1% is indicated for the topical treatment of acne vulgaris in patients aged 12 years and older.

  • lexette

    (Halobetasol propionate)
    Mayne Pharma
    LEXETTE® is indicated for the topical treatment of plaque psoriasis in patients aged 12 and older.

  • methylphenidate hydrochloride

    (Methylphenidate Hydrochloride)
    Mayne Pharma
    Methylphenidate hydrochloride extended-release capsules (LA) are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients aged 6 to 12 years.

  • nextstellis

    (drospirenone and estetrol)
    Mayne Pharma
    NEXTSTELLIS is indicated for females of reproductive potential to prevent pregnancy. However, it may be less effective in those with a BMI of 30 kg/m² or higher, with decreasing effectiveness linked to increasing BMI.

  • rhofade

    (oxymetazoline hydrochloride)
    Mayne Pharma
    RHOFADE® (oxymetazoline hydrochloride) cream, 1%, is indicated for the topical treatment of persistent facial erythema related to rosacea in adults.

  • sorilux

    (calcipotriene)
    Mayne Pharma
    SORILUX Foam is indicated for the topical treatment of plaque psoriasis in adults and pediatric patients aged 4 years and older, affecting both the scalp and body.